Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.
暂无分享,去创建一个
K. Lamborn | G. Denardo | S. Denardo | S. Shen | L. Miers | C. Meares | C. Richman | Q. Salako | L. Kroger | G. Zhong | J. Peterson | Jim Peterson